Los Angeles Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $810K | Buy |
24,371
+7,301
| +43% | +$218K | ﹤0.01% | 735 |
|
|
2025
Q4 | $581K | Hold |
17,070
| – | – | ﹤0.01% | 832 |
|
|
2025
Q3 | $617K | Buy |
17,070
+1,956
| +13% | +$64.4K | ﹤0.01% | 854 |
|
|
2025
Q2 | $544K | Buy |
15,114
+6,497
| +75% | +$242K | ﹤0.01% | 837 |
|
|
2025
Q1 | $340K | Sell |
8,617
-64,500
| -88% | -$2.17M | ﹤0.01% | 855 |
|
|
2024
Q4 | $2.2M | Sell |
73,117
-50,284
| -41% | -$1.44M | 0.01% | 433 |
|
|
2024
Q3 | $2.89M | Buy |
123,401
+31,124
| +34% | +$680K | 0.01% | 393 |
|
|
2024
Q2 | $1.64M | Buy |
92,277
+15,661
| +20% | +$250K | 0.01% | 497 |
|
|
2024
Q1 | $1.17M | Buy |
76,616
+27,437
| +56% | +$437K | ﹤0.01% | 647 |
|
|
2023
Q4 | $840K | Hold |
49,179
| – | – | ﹤0.01% | 730 |
|
|
2023
Q3 | $411K | Sell |
49,179
-2,032
| -4% | -$28.3K | ﹤0.01% | 877 |
|
|
2023
Q2 | $1.27M | Sell |
51,211
-10,046
| -16% | -$259K | 0.01% | 596 |
|
|
2023
Q1 | $921K | Sell |
61,257
-98,053
| -62% | -$1.49M | ﹤0.01% | 697 |
|
|
2022
Q4 | $1.88M | Sell |
159,310
-3,905
| -2% | -$28.3K | 0.01% | 529 |
|
|
2022
Q3 | $966K | Buy |
163,215
+36,509
| +29% | +$239K | 0.01% | 710 |
|
|
2022
Q2 | $539K | Buy |
126,706
+116,446
| +1,135% | +$727K | ﹤0.01% | 940 |
|
|
2022
Q1 | $98K | Buy |
+10,260
| New | +$119K | ﹤0.01% | 1389 |
|
|
2021
Q3 | – | Sell |
-7,505
| Closed | -$291K | – | 1592 |
|
|
2021
Q2 | $291K | Sell |
7,505
-4,545
| -38% | -$178K | ﹤0.01% | 1400 |
|
|
2021
Q1 | $581K | Buy |
+12,050
| New | +$579K | ﹤0.01% | 1154 |
|
|
2020
Q3 | – | Sell |
-11,598
| Closed | -$226K | – | 1525 |
|
|
2020
Q2 | $226K | Buy |
+11,598
| New | +$187K | ﹤0.01% | 1365 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
